We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.

LIVER FIBROSIS TREATMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2022 - 2030)

Liver Fibrosis Treatment Market, by Treatment Type (Peroxisome Proliferator-activated Receptors (PPAR)-alpha agonist, ACE Inhibitors, Hepatotropic Drug, and Others), by Condition (Chronic Liver Diseases, Hepatitis C, and Nonalcoholic Steatohepatitis), by Distribution Channel (Hospitals, Specialty Clinics, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In: 01 Aug, 2022
Code: CMI2320
Page number: 168
Formats: Excel and PDF
Industry: Pharmaceutical

Table of Contents (Version-2026)

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Treatment Type
  - Market Snapshot, By Condition
  - Market Snapshot, By Distribution Channel
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Impact Analysis
- Market Trends
- Recent Developments
- Acquisitions and Partnerships Scenario
- Technology Overview
- Regulatory Scenario
- Drug Pipeline Analysis
- Pricing Analysis
- PEST Analysis
Global Liver Fibrosis Treatment Market- Impact of Coronavirus (Covid-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the market
Global Liver Fibrosis Treatment Market, By Treatment Type, 2017 – 2030, (US$ Billion)
- Overview
  - Market Share Analysis, 2022 and 2030 (%)
  - Y-o-Y Growth Analysis, 2017 – 2030
  - Segment Trends
- Peroxisome Proliferator-activated Receptors (PPAR)-alpha agonist
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
- ACE Inhibitors
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
- Hepatotropic Drug
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
- Others
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
Global Liver Fibrosis Treatment Market, By Condition, 2017 – 2030, (US$ Billion)
- Overview
  - Market Share Analysis, 2022 and 2030 (%)
  - Y-o-Y Growth Analysis, 2017 – 2030
  - Segment Trends
- Chronic Liver Disease
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
- Hepatitis C
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
- Nonalcoholic Steatohepatitis
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
Global Liver Fibrosis Treatment Market, By Distribution Channel, 2017 – 2030, (US$ Billion)
- Overview
  - Market Share Analysis, 2022 and 2030 (%)
  - Y-o-Y Growth Analysis, 2017 – 2030
  - Segment Trends
- Hospitals
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
- Specialty Clinics
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
- Others
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
Global Liver Fibrosis Treatment Market, By Region, 2017 – 2030, (US$ Billion)
- Introduction
  - Market Share Analysis, By Region, 2022 and 2030 (%)
  - Y-o-Y Growth Analysis, For Regions, 2017–2030
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Condition, 2017 - 2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Billion)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Condition, 2017 - 2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Billion)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Condition, 2017 - 2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Billion)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Condition, 2017 - 2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Billion)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Condition, 2017 - 2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Billion)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Condition, 2017 - 2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 – 2030, (US$ Billion)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Company Profiles
  - Gilead Sciences, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Merck & Co., Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Bristol-Myers Squibb
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Johnson and Johnson
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Novartis AG
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Vertex Pharmaceuticals Incorporated
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Pfizer Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - FibroGen, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Pharmaxis Limited
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
Section
- References
- Research Methodology
- About Us and Sales Contact

*Browse 24 market data tables and 28 figures on "Global Liver Fibrosis Treatment Market” - forecast to 2030

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now